Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/13198
Full metadata record
DC FieldValueLanguage
dc.rights.licenseBY-NC-ND-
dc.contributor.authorAntonijević, Marko-
dc.contributor.authorĐorović Jovanović, Jelena-
dc.contributor.authorKesic, Ana-
dc.contributor.authorMilenković, Dejan-
dc.contributor.authorMarkovic, Zoran-
dc.date.accessioned2021-05-14T12:03:58Z-
dc.date.available2021-05-14T12:03:58Z-
dc.date.issued2021-
dc.identifier.isbn9788687611801en_US
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/13198-
dc.description.abstractThe pharmacologic properties of gold compounds have been known since the end of the 19th century. They have been used for different studies, even though they are usually used for the treatment of arthritis. In the last decade, gold complexes have received increased attention due to the variety of their applications. Primary, they have been investigated as potential anticancer and chemotherapeutic agents. It is well known that gold(III) complexes are very similar to platinum(II) compounds, so they could exhibit prospective anticancer, cytotoxic and antitumor properties. In this paper, were investigated the interactions of the gold(III) complexes, [Au(DPP)Cl2]+ and [Au(DMP)Cl3] where DPP=4,7-diphenyl-1,10-phenanthroline and DMP=2,9-dimethyl-1,10-phenanthroline) with SARS-CoV2 protease. The obtained results indicate that the square-planar [Au(DPP)Cl2]+ complex shows good inhibitory activity, compared to FDA approved drugs, cinanserin and chloroquine.en_US
dc.language.isosren_US
dc.publisherAgronomski fakulteten_US
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceXXVI SAVETOVANJE O BIOTEHNOLOGIJIen_US
dc.subjectcomplexen_US
dc.subjectgold (III)en_US
dc.subjectsynthesisen_US
dc.subjectmolecular dockingen_US
dc.subjectzlato (III)en_US
dc.subjectmolekulski dokingen_US
dc.titleКOMPLEKSI ZLATA KAO POTENCIJALNI SUPLEMENTI SA ANTIKANCEROGENIM I ANTIVIRUSNIM DELOVANJEMen_US
dc.typeconferenceObjecten_US
dc.description.versionPublisheden_US
dc.identifier.doi10.46793/SBT26.429Aen_US
dc.relation.conferenceXXVI SAVETOVANJE O BIOTEHNOLOGIJIen_US
dc.type.versionPublishedVersionen_US
Appears in Collections:Faculty of Science, Kragujevac
Institute for Information Technologies, Kragujevac

Page views(s)

219

Downloads(s)

87

Files in This Item:
File Description SizeFormat 
429-434.pdf1.2 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons